NEW YORK (GenomeWeb News) — ProMetic Life Sciences has closed CA$6.6 million ($6.4 million) by selling 18.9 million subordinate shares for CA$.35 a share, the Montreal-based company said Tuesday.
ProMetic said it issued 13.3 million shares to Paradigm Capital for CA$4.7 million and 5.5 million shares to unidentified US institutional investors for CA$1.9 million.
Rodman & Renshaw Capital Group served as financial advisers for the financing, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.